APA (7th ed.) Citation

Chua, W., Law, J. P., Cardoso, V. R., Purmah, Y., Neculau, G., Jawad-Ul-Qamar, M., . . . Fabritz, L. (2021). Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study. PLoS Medicine, 18(2), 1. https://doi.org/10.1371/journal.pmed.1003405

Chicago Style (17th ed.) Citation

Chua, Winnie, et al. "Quantification of Fibroblast Growth Factor 23 and N-terminal Pro-B-type Natriuretic Peptide to Identify Patients with Atrial Fibrillation Using a High-throughput Platform: A Validation Study." PLoS Medicine 18, no. 2 (2021): 1. https://doi.org/10.1371/journal.pmed.1003405.

MLA (9th ed.) Citation

Chua, Winnie, et al. "Quantification of Fibroblast Growth Factor 23 and N-terminal Pro-B-type Natriuretic Peptide to Identify Patients with Atrial Fibrillation Using a High-throughput Platform: A Validation Study." PLoS Medicine, vol. 18, no. 2, 2021, p. 1, https://doi.org/10.1371/journal.pmed.1003405.